ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2
Publication date
2015-09
Authors
Cillessen, Saskia A G M
Hijmering, Nathalie J
Moesbergen, Laura M
Vos, Wim
Verbrugge, S J
Jansen, Gerrit
Visser, Otto J
Oudejans, Joost J
Meijer, Chris J L M
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Clinical Trial, Letter, Research Support, Non-U.S. Gov't
Citation
Cillessen, S A G M, Hijmering, N J, Moesbergen, L M, Vos, W, Verbrugge, S E, Jansen, G, Visser, O J, Oudejans, J J & Meijer, C J L M 2015, 'ALK-negative anaplastic large cell lymphoma is sensitive to bortezomib through Noxa upregulation and release of Bax from Bcl-2', Haematologica, vol. 100, no. 9, pp. e365-8. https://doi.org/10.3324/haematol.2014.118828